Orphazyme A/S (ORPHA.CO)

DKK 1120.0

(-2.61%)

Eps Summary of Orphazyme A/S

Orphazyme A/S's latest annual eps in 2023 was -0.74 DKK , up 76.43% from previous year.
Orphazyme A/S's latest quarterly eps in 2024 Q2 was 0.03 DKK , down 0.0% from previous quarter.
Orphazyme A/S reported an annual eps of -3.14 DKK in 2022, up 82.5% from previous year.
Orphazyme A/S reported an annual eps of -17.94 DKK in 2021, up 19.62% from previous year.
Orphazyme A/S reported a quarterly eps of 0.03 DKK for 2024 Q2, down 0.0% from previous quarter.
Orphazyme A/S reported a quarterly eps of -0.38 DKK for 2023 Q4, down -189900.0% from previous quarter.

Annual Eps Chart of Orphazyme A/S (2023 - 2015)

Historical Annual Eps of Orphazyme A/S (2023 - 2015)

Year	Eps	Eps Growth
2023	-0.74 DKK	76.43%
2022	-3.14 DKK	82.5%
2021	-17.94 DKK	19.62%
2020	-22.32 DKK	-32.31%
2019	-16.87 DKK	-47.08%
2018	-11.47 DKK	-9.97%
2017	-10.43 DKK	-77.08%
2016	-5.89 DKK	-26.39%
2015	-4.66 DKK	0.0%

Year	Eps	Eps Growth
2024 Q1	- DKK	100.0%
2024 Q2	0.03 DKK	0.0%
2023 Q4	-0.38 DKK	-189900.0%
2023 Q3	-0.00 DKK	99.94%
2023 Q1	-0.00 DKK	99.98%
2023 Q2	-0.36 DKK	-179900.0%
2023 FY	- DKK	76.48%
2022 Q1	-0.00 DKK	99.99%
2022 Q4	-1.04 DKK	0.0%
2022 FY	- DKK	82.52%
2022 Q2	-2.35 DKK	-783233.33%
2021 Q1	-0.00 DKK	99.99%
2021 FY	- DKK	19.64%
2021 Q3	-0.00 DKK	99.98%
2021 Q4	-4.66 DKK	-194066.67%
2021 Q2	-13.29 DKK	-1661150.0%
2020 Q1	-0.01 DKK	99.94%
2020 FY	- DKK	-32.31%
2020 Q4	-12.44 DKK	-200545.16%
2020 Q3	-0.01 DKK	99.94%
2020 Q2	-9.88 DKK	-197500.0%
2019 Q1	-0.00 DKK	-43.33%
2019 Q3	-0.00 DKK	99.95%
2019 Q2	-8.21 DKK	-190830.23%
2019 Q4	-8.69 DKK	-201993.02%
2019 FY	- DKK	-147006.89%
2018 Q3	-0.00 DKK	-7.14%
2018 Q4	-0.00 DKK	0.0%
2018 Q2	-0.00 DKK	0.0%
2018 FY	- DKK	-9.97%
2018 Q1	-0.00 DKK	0.0%
2017 Q2	-0.00 DKK	0.0%
2017 Q3	-0.00 DKK	-7.69%
2017 Q4	-0.00 DKK	0.0%
2017 FY	- DKK	-77.08%
2017 Q1	-0.00 DKK	-73.33%
2016 Q4	-0.00 DKK	0.0%
2016 FY	- DKK	-26.39%
2016 Q2	-0.00 DKK	0.0%
2016 Q1	-0.00 DKK	0.0%
2016 Q3	-0.00 DKK	-7.14%
2015 FY	- DKK	0.0%

Peer Eps Comparison of Orphazyme A/S

Name	Eps	Eps Difference
ALK-Abelló A/S	2.20 DKK	133.636%
Bavarian Nordic A/S	19.23 DKK	103.848%
Genmab A/S	66.64 DKK	101.11%
Gubra A/S	-2.93 DKK	74.744%
Novo Nordisk A/S	18.67 DKK	103.964%
Pharma Equity Group A/S	-0.02 DKK	-3145.614%
Zealand Pharma A/S	-12.44 DKK	94.051%